Diabetic Neuropathy Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: D08E76A781D5EN
Market Monitor Global

Abstracts

Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage.

This report contains market size and forecasts of Diabetic Neuropathy Treatment in Global, including the following market information:

Global Diabetic Neuropathy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetic Neuropathy Treatment market was valued at 4676.5 million in 2021 and is projected to reach US$ 6114.5 million by 2028, at a CAGR of 3.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Peripheral Neuropathy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Neuropathy Treatment include Abbott, Roche, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, Lupin, Glenmark, Depomed and Astellas and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Neuropathy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Neuropathy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Neuropathy Treatment Market Segment Percentages, by Type, 2021 (%)

• Peripheral Neuropathy
• Autonomic Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

Global Diabetic Neuropathy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Neuropathy Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Diabetic Neuropathy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetic Neuropathy Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetic Neuropathy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetic Neuropathy Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Roche
• Eli Lilly
• Johnson & Johnson
• GlaxoSmithKline
• Lupin
• Glenmark
• Depomed
• Astellas
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetic Neuropathy Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetic Neuropathy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETIC NEUROPATHY TREATMENT OVERALL MARKET SIZE

2.1 Global Diabetic Neuropathy Treatment Market Size: 2021 VS 2028
2.2 Global Diabetic Neuropathy Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetic Neuropathy Treatment Players in Global Market
3.2 Top Global Diabetic Neuropathy Treatment Companies Ranked by Revenue
3.3 Global Diabetic Neuropathy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Neuropathy Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Neuropathy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Neuropathy Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Diabetic Neuropathy Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetic Neuropathy Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetic Neuropathy Treatment Market Size Markets, 2021 & 2028
  4.1.2 Peripheral Neuropathy
  4.1.3 Autonomic Neuropathy
  4.1.4 Proximal Neuropathy
  4.1.5 Focal Neuropathy
4.2 By Type - Global Diabetic Neuropathy Treatment Revenue & Forecasts
  4.2.1 By Type - Global Diabetic Neuropathy Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Diabetic Neuropathy Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetic Neuropathy Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Diabetic Neuropathy Treatment Revenue & Forecasts
  5.2.1 By Application - Global Diabetic Neuropathy Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Diabetic Neuropathy Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetic Neuropathy Treatment Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Neuropathy Treatment Revenue & Forecasts
  6.2.1 By Region - Global Diabetic Neuropathy Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Diabetic Neuropathy Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetic Neuropathy Treatment Revenue, 2017-2028
  6.3.2 US Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.3.3 Canada Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.3.4 Mexico Diabetic Neuropathy Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetic Neuropathy Treatment Revenue, 2017-2028
  6.4.2 Germany Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.4.3 France Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.4.4 U.K. Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.4.5 Italy Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.4.6 Russia Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.4.8 Benelux Diabetic Neuropathy Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetic Neuropathy Treatment Revenue, 2017-2028
  6.5.2 China Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.5.3 Japan Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.5.4 South Korea Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.5.6 India Diabetic Neuropathy Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetic Neuropathy Treatment Revenue, 2017-2028
  6.6.2 Brazil Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.6.3 Argentina Diabetic Neuropathy Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetic Neuropathy Treatment Revenue, 2017-2028
  6.7.2 Turkey Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.7.3 Israel Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetic Neuropathy Treatment Market Size, 2017-2028
  6.7.5 UAE Diabetic Neuropathy Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Diabetic Neuropathy Treatment Major Product Offerings
  7.1.4 Abbott Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Diabetic Neuropathy Treatment Major Product Offerings
  7.2.4 Roche Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Diabetic Neuropathy Treatment Major Product Offerings
  7.3.4 Eli Lilly Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Diabetic Neuropathy Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Diabetic Neuropathy Treatment Major Product Offerings
  7.5.4 GlaxoSmithKline Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Lupin
  7.6.1 Lupin Corporate Summary
  7.6.2 Lupin Business Overview
  7.6.3 Lupin Diabetic Neuropathy Treatment Major Product Offerings
  7.6.4 Lupin Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.6.5 Lupin Key News
7.7 Glenmark
  7.7.1 Glenmark Corporate Summary
  7.7.2 Glenmark Business Overview
  7.7.3 Glenmark Diabetic Neuropathy Treatment Major Product Offerings
  7.7.4 Glenmark Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.7.5 Glenmark Key News
7.8 Depomed
  7.8.1 Depomed Corporate Summary
  7.8.2 Depomed Business Overview
  7.8.3 Depomed Diabetic Neuropathy Treatment Major Product Offerings
  7.8.4 Depomed Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.8.5 Depomed Key News
7.9 Astellas
  7.9.1 Astellas Corporate Summary
  7.9.2 Astellas Business Overview
  7.9.3 Astellas Diabetic Neuropathy Treatment Major Product Offerings
  7.9.4 Astellas Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.9.5 Astellas Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Diabetic Neuropathy Treatment Major Product Offerings
  7.10.4 Pfizer Diabetic Neuropathy Treatment Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetic Neuropathy Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetic Neuropathy Treatment Market Drivers in Global Market
Table 3. Diabetic Neuropathy Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetic Neuropathy Treatment in Global Market
Table 5. Top Diabetic Neuropathy Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Neuropathy Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Neuropathy Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Neuropathy Treatment Product Type
Table 9. List of Global Tier 1 Diabetic Neuropathy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Neuropathy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Neuropathy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Neuropathy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Neuropathy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Neuropathy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Neuropathy Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Neuropathy Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Diabetic Neuropathy Treatment Product Offerings
Table 32. Abbott Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Diabetic Neuropathy Treatment Product Offerings
Table 35. Roche Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Diabetic Neuropathy Treatment Product Offerings
Table 38. Eli Lilly Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Diabetic Neuropathy Treatment Product Offerings
Table 41. Johnson & Johnson Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Diabetic Neuropathy Treatment Product Offerings
Table 44. GlaxoSmithKline Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Lupin Corporate Summary
Table 46. Lupin Diabetic Neuropathy Treatment Product Offerings
Table 47. Lupin Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Glenmark Corporate Summary
Table 49. Glenmark Diabetic Neuropathy Treatment Product Offerings
Table 50. Glenmark Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Depomed Corporate Summary
Table 52. Depomed Diabetic Neuropathy Treatment Product Offerings
Table 53. Depomed Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Astellas Corporate Summary
Table 55. Astellas Diabetic Neuropathy Treatment Product Offerings
Table 56. Astellas Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Diabetic Neuropathy Treatment Product Offerings
Table 59. Pfizer Diabetic Neuropathy Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetic Neuropathy Treatment Segment by Type in 2021
Figure 2. Diabetic Neuropathy Treatment Segment by Application in 2021
Figure 3. Global Diabetic Neuropathy Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Neuropathy Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Neuropathy Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Neuropathy Treatment Revenue in 2021
Figure 8. By Type - Global Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 12. US Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 24. China Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Neuropathy Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Neuropathy Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lupin Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Glenmark Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Depomed Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astellas Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Diabetic Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)